Related Experiment Video
Updated: Aug 30, 2025
Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
Published on: January 23, 2018
Patient-Reported Pain and Function Outcomes in Children With Congenital Vertical Talus Treated With the Minimally
Jason L Cummings1, Pooya Hosseinzadeh
1Department of Orthopaedic Surgery, Washington University, St. Louis, MO.
Insights
Minimally invasive surgery for congenital vertical talus (CVT) shows good long-term quality of life outcomes. Early treatment before 12 months of age is crucial for optimal mobility scores in pediatric patients.
Area of Science:
- Orthopedics
- Pediatric Surgery
- Quality of Life Research
Background:
- Congenital vertical talus (CVT) is a complex foot deformity.
- A minimally invasive surgical approach was introduced in 2006 for CVT correction.
- No studies have evaluated long-term quality of life using Patient-Reported Outcome Measurement Information System (PROMIS) in CVT patients.
Purpose of the Study:
- To assess long-term quality of life outcomes in pediatric patients treated for CVT using a minimally invasive method.
- To evaluate PROMIS scores in pain interference, mobility, and peer relations.
- To identify factors influencing outcomes, including recurrence and age at treatment initiation.
Main Methods:
- Retrospective chart review of pediatric patients treated for CVT with a minimally invasive method after 2015.
- Collection of PROMIS scores for pain interference, mobility, and peer relations.
- Subgroup analysis for patients with recurrence or requiring a second surgery.
Main Results:
- 24 children with CVT completed PROMIS surveys; 29.2% experienced recurrence.
- Mean PROMIS scores: Pain Interference 48±9, Mobility 42±13, Peer Relations 54±9.
- No significant difference in PROMIS scores between recurrent and non-recurrent cases.
- Children treated after 12 months had significantly lower mobility scores (P=0.02).
Conclusions:
- Children treated with this minimally invasive technique generally achieve PROMIS scores within 1 SD of the reference population.
- A trend towards lower mobility scores was observed compared to the general population.
- Initiating CVT treatment before 12 months of age is recommended to improve patient-reported outcomes, particularly mobility.
Background:
In 2006, a new minimally invasive method was introduced for the definitive correction of congenital vertical talus (CVT) deformity. There are no studies to date that have utilized the Patient-Reported Outcome Measurement Information System (PROMIS) to evaluate long-term quality of life outcomes in these patients.
Methods:
We identified all children with CVT who underwent treatment with the minimally invasive method and were seen at our institution after 2015. A retrospective chart review was then performed on these patients, and PROMIS scores were recorded for the following domains: Pain Interference, Mobility, and Peer Relations. Subgroup analysis was performed on patients who experienced recurrence and those who required a second corrective surgery. An alpha level of 0.05 was used for all analyses.
Results:
There were 24 children who were treated for CVT at our institution after 2015 and had completed PROMIS surveys. Seven (29.2%) of these patients developed recurrence during the follow-up period. Among the entire cohort, the mean PROMIS pain interference score was 48±9, the mean PROMIS mobility score was 42±13, and the mean PROMIS peer relations score was 54±9. There were no statistically significant differences in the PROMIS scores between the entire cohort and those who experienced radiographic recurrence in any of the 3 domains ( P >0.05). Children who initiated treatment after the age of 12 months had lower PROMIS mobility scores than those who initiated treatment before 12 months of age (32.48 vs. 47.31, P =0.02).
Conclusion:
On average, children who undergo treatment with this technique end up within 1 SD of the reference population in all 3 domains that were measured (pain interference, mobility, and peer relations) regardless of sex, age, and status of recurrence. However, there was a trend towards lower mobility scores in this population compared with the reference population (42±13 vs. 50±10). Treatment should be initiated at less than 12 months of age whenever possible to maximize patient-reported outcomes.
Level Of Evidence:
Level III.
More Related Videos
09:01Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach
Published on: January 24, 2018
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024